Barnes-Jewish Hospital in St. Louis and Research Medical Center of Kansas City, Mo., have been recognized with Donate Life Award honors for their exceptional leadership in raising awareness of organ and tissue donation and transplantation.
The awards were presented on Thursday, Nov. 2, during an awards luncheon at the Missouri Hospital Association’s 95th Annual Convention & Trade Show in Osage Beach, Mo.
Two organ procurement organizations provide services in Missouri. Mid-America Transplant leads the regional organ, tissue and eye donation programs throughout Eastern and Southern Missouri, Southern Illinois and Northeastern Arkansas. Midwest Transplant Network leads donation and transplantation efforts for Western Missouri and Kansas.
Mid-America Transplant recognized Barnes-Jewish Hospital with their Donate Life Award.
Barnes-Jewish Hospital earned a Donate Life Award from Mid-America Transplant Services for its leadership and commitment to organ donation and transplantation. Throughout the year, the hospital holds events to promote organ and tissue donation and transplantation. The hospital has a multi-disciplinary Donor Council that works on education and management of donation issues. In addition, hospital staff work closely with the organ procurement organization to implement practices that support donation and transplantation. The hospital has a 100 percent timely referral rate, declaration rate and collaborative approach rate for potential vital organ donors. Its 67 percent conversion rate exceeds the MTS average.
Midwest Transplant Network recognized Research Medical Center with their Donate Life Award.
Research Medical Center of Kansas City earned a Donate Life Award from Midwest Transplant Network for its leadership and commitment to organ donation and transplantation. The hospital exceeded the national goal for donation and transplantation by 4 percent, and the Centers for Medicare & Medicaid Services benchmark by nearly 20 percent. A member of MTN attends the hospital trauma department’s monthly meeting to ensure accountability process and outcomes for patients, while balancing the opportunity for patients to donate if options for a positive outcome are exhausted. Organ and tissue conversion rates have been consistent or improved in each of the past four years.